Skip to main content
Egyptian Liver Journal
Download PDF
  • Original Research Article
  • Open access
  • Published:

Prevalence of esophageal eosinophilia in patients referred for diagnostic upper gastrointestinal endoscopy

Egyptian Liver Journal volume 11, Article number: 63 (2021) Cite this article

Abstract

Background

Several conditions are associated with esophageal eosinophilia such as eosinophilic esophagitis (EoE) and gastro-esophageal reflux disease (GERD). The aim of this study was to detect the prevalence of esophageal eosinophilia in patients with upper gastrointestinal (GI) symptoms referred for diagnostic upper GI endoscopy. This study included 86 patients who underwent upper GI endoscopy and biopsies.

Results

Esophageal eosinophilia EE was found in 26 patients (30.2%): 3 patients (3.5%) had EoE and 23 patients (26.7%) had low-grade esophageal eosinophilia. The most common presenting symptoms were heart burn in 84 patients (97.7%) and upper abdominal pain in 78 patients (90.7%). Reflux esophagitis (ERD) was observed in 18.6% of patients. In histopathological examination, EoE was found in 3.5%, mild reflux esophagitis in 37.2%, and severe reflux esophagitis in 16.3%. There is statistically significant correlation between EE and male sex, hypertension, dysphagia, hiatus hernia, incompetent cardia, and fixed rings. Age, incompetent cardia, and dysphagia were statistically significant independent predictors of low-grade EE.

Conclusion

Esophageal eosinophilia EE was found in 30.2% of patients: 3.5% had eosinophilic esophagitis EoE and 26.7% had low-grade esophageal eosinophilia.

Background

Under physiological conditions, eosinophils are present throughout the gastrointestinal tract distal to the squamous esophagus [1]. Several conditions are associated with esophageal eosinophilia (EE) such as eosinophilic esophagitis (EoE), gastro-esophageal reflux disease (GERD), eosinophilic gastritis, gastroenteritis, or colitis with esophageal involvement, esophageal motility disorders such as achalasia, Crohn’s disease with esophageal involvement, infections (fungal, viral), and hypereosinophilic syndrome [2, 3]. In the clinical setting, some of them are frequent such as GERD and EoE [2]. Eosinophilic esophagitis was first reported as the esophageal involvement of eosinophilic gastroenteritis (EGE) in 1977. Thereafter, this condition had been considered a subtype of (GERD). In 1993, Attwood et al. published the first case series of EoE as a distinct disease entity different to GERD or secondary EE [4]. Several risk factors and mechanisms have been described by which external environmental agents and factors inherent to each person may lead to EoE. The diagnosis of EoE requires all of the following: symptoms related to esophageal dysfunction, eosinophil-predominant inflammation on esophageal biopsy, characteristically consisting of a peak value of ≥ 15 eosinophils per high-power field (HPF) (or 60 eosinophils per mm2), and exclusion of other causes that may be responsible for or contributing to symptoms and esophageal eosinophilia [2]. The most common symptom of EoE in adults is dysphagia [5]. Endoscopic findings of EoE are frequently described using the EoE endoscopic reference score (EREFS), which stands for the five key findings (edema, rings, exudates, furrows, and strictures) [6]. In addition, the endoscopic appearance of the esophagus may be normal in 10 to 25% of patients with EoE [7]. A histological diagnosis is confirmed when there are ≥ 15 eosinophils per high-power field (HPF) [2]. Currently, the recommendation is to take at least six biopsies from two different sites, typically from the distal and proximal esophagus [8]. The diagnostic sensitivity increased to almost 100% with five or more biopsies [4]. The therapeutic approach consists of the “3D” concept: diet, drugs, and dilation [4]. Current United European Gastroenterology guidelines recommend swallowed topical corticosteroids (STCs), high-dose PPI, or elimination diet for the initial treatment of EoE [9]. GERD has been defined by the Montreal Classification as a condition that occurs due to retrograde flow of gastric contents into the esophagus that lead to troublesome symptoms, which are typically heartburn and regurgitation [10]. GERD can be classified as erosive reflux disease (ERD) or non-erosive reflux disease (NERD) [11].

Objectives

To detect the prevalence of esophageal eosinophilia in patients with upper GI symptoms referred for diagnostic upper GI endoscopy.

Methods

Study design

The present study was a cross-sectional prevalence study.

Settings

The study was conducted at Mansoura Specialized Medical Hospital.

Participants

This study included 86 adult patients with unexplained upper GI symptoms referred for diagnostic upper GI endoscopy at Mansoura Specialized Medical Hospital.

Variables

Inclusion criteria

Adult patients (> 18 years) with unexplained upper GI symptoms (dysphagia, heartburn, nausea, vomiting, and upper abdominal pain) referred for diagnostic upper GI endoscopy at Specialized Medical Hospital, Mansoura University.

Exclusion criteria

Patients with the following:

  • Advanced heart failure.

  • Chronic liver disease.

  • Chronic kidney disease.

Malignancy.

  • Other causes of esophageal eosinophilia as achalasia, Crohn’s disease and infections such as candidal esophagitis, connective tissue disorders, and hypereosinophilic syndrome.

Data sources/measurement

All selected patients were subjected to careful history taking, physical examination, laboratory tests including complete blood count (CBC), differential leucocytic count, serum creatinine, liver biochemical tests, abdominal ultrasound, upper GI endoscopy (esophagitis endoscopic reference score was used to minimize observer variability), biopsy (6 esophageal and 4 antral biopsies) and lastly, histopathological examination by staining the biopsies with hematoxylin and eosin (H&E). On the high-power field, the pathologist counted the eosinophils. The presence of more than 15 eosinophils/HPF was diagnostic for EoE and presence of less than 15 eosinophils/HPF indicates low-grade EE.

Bias

N/A

Study size

The study size is determined by the statistician.

Quantitative variables

N/A

Statistical methods

Data were entered and analyzed using IBM-SPSS software (IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp.)

Results

EE was found in 26 patients (30.2%): 3 patients (3.5%) had EoE and 23 patients (26.7%) had low-grade esophageal eosinophilia as shown in Table 1.

Table 1 Descriptive statistics of demographic, clinical, endoscopic and histopathological parameters of the studied cases (N = 86)
Full size table

The most common presenting symptoms were heart burn in 84 patients (97.7%) and upper abdominal pain in 78 patients (90.7%) as shown in Table 1.

Reflux esophagitis (ERD) was observed in 18.6% of patients as shown in Table 1.

In histopathological examination, EoE was found in 3.5%, mild reflux esophagitis in 37.2%, and severe reflux esophagitis in 16.3% as shown in Tables 1 and 1.

There is statistically significant correlation between EE and proportions of male sex, hypertension, dysphagia, hiatus hernia, incompetent cardia, and fixed rings as shown in Table 2.

Table 2 Correlation between EE as an ordinal variable and dichotomous study variables
Full size table

Age, incompetent cardia, and dysphagia were statistically significant independent predictors of low-grade EE as shown in Table 3.

Table 3 Predictors of the likelihood of low-grade EE vs absent EE
Full size table

This table showed that 62 patients (72.1%) live in rural areas and 24 patients (27.9%) in urban areas. The most common symptoms were heart burn in 84 patients (97.7%) and upper abdominal pain in 78 patients (90.7%), while dysphagia was observed in 22 patients (25.6%). Current smoking in 14 (16.3%) patients, atopy in 8 (9.3%), and PPI use in 76 (88.4%) patients with median duration of 3 months (0–12).

On endoscopic examination, reflux esophagitis was observed in 18.6%, incompetent cardia in 48.8% and fixed rings in 7% of patients. Gastritis was observed in 59 patients 68.6% (45 antral and 14 pan gastritis).

On histopathological examination, EE was found in 26 patients (30.2%): 3 patients (3.5%) had EoE and 23 patients (26.7%) had low-grade esophageal eosinophilia (< 15 eosinophils/HPF). Mild reflux esophagitis was found in 37.2%, severe reflux esophagitis in 16.3%, and H. pylori-associated gastritis in 48.8% of cases.

This table shows that EoE cases were males, and their age range from 34 to 73 years. One patient was a smoker. All 3 patients had recent history of PPI use (for 2–4 months). All patients had dysphagia, upper abdominal pain, and heart burn. No one had atopy. No one had peripheral eosinophilia. WBCs, hemoglobin, and platelets were within normal range. In upper GI endoscopy, 2 patients had fixed rings while 1 patient had normal appearing mucosa. Incompetent cardia and hiatus hernia were observed in 1 patient. ERD was not observed in any patient. According to histopathological findings, basal cell hyperplasia and dilated intercellular space were observed in all patients, but there was no papillary elongation. Intra epithelial eosinophils were ≥ 15. There was severe reflux esophagitis in the patient. All 3 patients had H. pylori in gastric biopsy.

This table showed a statistically significant correlation between EE and proportions of male sex, hypertension, dysphagia, hiatus hernia, incompetent cardia, and fixed rings.

As the proportions of male sex, hypertension, dysphagia, hiatus hernia, incompetent cardia, and fixed rings go up, the grading of EE goes up. No statistically significant correlation with other dichotomous variables.

This table showed the results of binary logistic regression analysis that was run to ascertain the effects of age ≥ 46 years, incompetent cardia, presence of dysphagia, and hypertension on the likelihood that participants will exhibit low-grade EE. Univariate analysis showed that each of the four predictor variables was statistically significant. On running multivariate analysis, only age, incompetent cardia, and dysphagia were statistically significant independent predictors of low-grade EE.

The model was statistically significant (χ2 [4] = 27.338, P < 0.001).

The model correctly classified 75.9% of cases with sensitivity of 56.5% and specificity of 83.3%.

Participants with older age (≥ 46), incompetent cardia, and dysphagia had 4.4, 5.8, and 4.3 times higher odds to exhibit low-grade EE.

Participants

This study included 86 adult patients with unexplained upper GI symptoms referred for diagnostic upper GI endoscopy at Mansoura Specialized Medical Hospital.

Descriptive data, outcome data, and main results

Descriptive data, outcome data, and main results are shown in Tables 1, 2 and 3.

Other analyses

N/A

Key results

EE was found in 26 patients (30.2%): 3 patients (3.5%) had EoE and 23 patients (26.7%) had low-grade esophageal eosinophilia.

The most common presenting symptoms were heart burn in 84 patients (97.7%) and upper abdominal pain in 78 patients (90.7%). Reflux esophagitis (ERD) was observed in 16 patients (18.6%). In histopathological examination, EoE was found in 3 patients (3.5%), mild reflux esophagitis in 32 patients (37.2%), and severe reflux esophagitis in 14 patients (16.3%). EoE patients were 3 males and had dysphagia but no history of atopy. Two EoE patients had fixed rings while 1 patient had normal appearing mucosa. There is statistically significant correlation between EE and proportions of male sex, hypertension, dysphagia, hiatus hernia, incompetent cardia, and fixed rings. Age, incompetent cardia, and dysphagia were statistically significant independent predictors of low-grade EE.

Discussion

The present study included 86 patients with upper GI symptoms referred for upper GI endoscopy. Eosinophils are not present in the esophagus under normal conditions [1]. Eosinophilic esophagitis diagnosis should be confirmed histologically based on the presence of more than 15 eosinophils per high-power field and the exclusion of other causes of eosinophilia [7].

Therefore, the aim of our study was to detect the prevalence of esophageal eosinophilia in patients with upper gastrointestinal (GIT) symptoms referred for diagnostic upper GIT endoscopy. In the current study, 14 patients (16.3%) were smokers, 4 patients (4.7%) had D.M, 10 patients (11.6%) had hypertension, 8 patients (9.3%) had atopy, 8 patients (9.3%) had history of recent NSAIDs use, and 76 patients (88.4%) were with recent history of PPIs use with median duration of 3 months. In similar study conducted by Hunter et al. (2014) [12] on 91 adult patients presenting with various upper gastrointestinal symptoms, they found that 61.5% of patients were males and 38.4% were females. One third of the patients gave history of smoking and 71% gave history of PPIs use. In our study, the most common presenting symptom was heart burn which is present in 84 patients (97.7%) followed by upper abdominal pain in 78 patients (90.7%). In contrast, in an Egyptian study conducted in El-Minia University, the upper abdominal pain was the most common symptom and reported in 63.3% then heartburn in 50% of patients [13]. In our study, the most common histopathological finding was that of reflux esophagitis which was found in 46 cases (53.5%): mild reflux esophagitis in 32 cases (37.2%) and severe reflux esophagitis in 14 cases (16.3%). EoE was observed in 3 cases (3.5%); 1 case of them has histopathological findings of reflux esophagitis. Thirty-eight cases had normal esophageal biopsy. H. pylori was found in 42 cases (48.8%) of cases.

In our study, we found 26 cases (30.2%) with EE, 3 cases (3.5%) had high-grade esophageal eosinophilia (≥ 15/HPF) which fulfill the diagnostic criteria of eosinophilic esophagitis, 23 cases (26.7%) had low-grade esophageal eosinophilia (< 15/HPF), but 60 cases (69.8%) had absent esophageal eosinophilia.

Also, there is an Egyptian study that showed the prevalence of EoE in patients with upper GI symptoms was 1.8% [13].

This discrepancy in prevalence rate is related to many factors: first, differences in demographic data (i.e., age group, gender predominance, race, and ethnicity) of patients included in each study; second, using different diagnostic criteria of eosinophilic esophagitis; and third, the complex interplay between eosinophilic esophagitis and GERD which can lead to many conflicting results [14].

In our study, the 3 cases of eosinophilic esophagitis were male, and their age range was from 34 to 73 years. One case was a smoker. All 3 cases had recent history of PPI use (for 2–4 months).

All 3 patients had dysphagia, upper abdominal pain, and heart burn. None had atopy nor peripheral eosinophilia.

Sawada et al. (2019) [15] analyzed a total of 106 patients with EoE and a median age of 46 years (range 41–52). Similarly, the majority of patients were male (65%) and most patients (89%) had symptoms including dysphagia (69 %). However, heartburn and chest pain represented (25 and 15%), respectively, and 70% of patients had comorbidities of allergic diseases.

In agreement with our study, Fouad et al. (2018) [13] had found that EoE is more common in males than in females (3:1) with mean age 34.3 ± 6.0 years. But no one was smoker and all had normal stomach and duodenal endoscopic findings.

In the present study, reflux esophagitis (ERD) was observed in 18% by endoscopy while by biopsy, we found mild reflux esophagitis in 37.2% and severe reflux esophagitis in 16.3% in spite of normal appearing mucosa.

So, it is suggested to obtain an endoscopic biopsy in spite of normal appearing lower esophageal mucosa in patients with GERD symptoms, in those with incompetent cardia, in those who are currently smoking, or in those with hiatus hernia, particularly in male patients.

In our study, we found statistically significant correlation between EE and proportions of male sex, hypertension, dysphagia, hiatus hernia, incompetent cardia, and fixed rings.

Also age, incompetent cardia, and dysphagia were statistically significant independent predictors of low-grade EE.

Similarly, Ravi et al. 2011 [16] found that patients with low-grade esophageal eosinophilia were older (48 ± 2.1) and showed a male predominance. Dysphagia was the most common presenting symptom as present in 83% of patients, and the fixed esophageal rings was the most common endoscopic finding, as seen in 37% of patients.

In the current study, the fixed rings (trachealization) were present in 6 patients (7%): 2 of them were diagnosed to have EoE and the other 4 patients had low-grade EE. This can be explained by that the fixed rings are non-pathognomonic as mentioned by Braunberger et al. (2020) [17]. Our 3 EoE cases had recent history of PPI use (for 2–4 months) with no improvement of their symptoms which exclude PPI-responsive esophageal eosinophilia (PPI-REE) as there are no significant clinical, histological, and endoscopic characteristics that distinguish PPI-REE from EoE (Eluri and Dellon 2015) [18] despite the efficacy of PPI as stated by Young, 2020 [19].

Limitations

Considering the limited subjects, only 86 patients were included in the study, so our results should be interpreted with caution. Further studies are needed to evaluate patients with low-grade eosinophilia.

Interpretation

Our results should be interpreted with caution because of several limitations. We recruited 86 patients in this study, and the sample size is relatively small which may restrict the subgroups analysis. All participants were from Mansoura Specialized Medical Hospital which may not stand for all the Egyptian population.

Generalizability

The fundamental experiments should be further conducted to validate our results and explore the possible mechanism.

Conclusion

EE was found in 26 patients (30.2%): 3 patients (3.5%) had EoE and 23 patients (26.7%) had low-grade EE. EoE prevalence has evolved in the last 2 decades and varies according to different population. Many predictors for low-grade EE has been identified but still its clinical significance is not clearly defined and further studies are recommended.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

EE:

Esophageal eosinophilia

EoE:

Eosinophilic esophagitis

GERD:

Gastro-esophageal reflux disease

ERD:

Erosive reflux disease

NERD:

Non-erosive reflux disease

GI:

Gastrointestinal

HPF:

High-power field

H&E:

Hematoxylin and eosin

DM:

Diabetes mellitus

PPI:

Proton pump inhibitor

PPI-REE:

PPI-responsive esophageal eosinophilia

EGE:

Eosinophilic gastroenteritis

References

  1. Walker MM, Potter M, Talley NJ (2018) Eosinophilic gastroenteritis and other eosinophilic gut diseases distal to the oesophagus. Lancet Gastroenterol Hepatol 3(4):271–280. https://doi.org/10.1016/S2468-1253(18)30005-0

    Article  PubMed  Google Scholar 

  2. Dellon ES et al (2018) Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference. Gastroenterology 155(4):1022–1033.e10

    Article  Google Scholar 

  3. Reed CC, Dellon ES (2019) Eosinophilic esophagitis. Med Clin North Am 103(1):29–42. https://doi.org/10.1016/j.mcna.2018.08.009

    Article  PubMed  Google Scholar 

  4. et al (2017) Diagnosis and treatment of eosinophilic esophagitis in clinical practice. Clin J Gastroenterol 10(2):87–102. https://doi.org/10.1007/s12328-017-0725-4Abe, Y.et al, Diagnosis and treatment of eosinophilic esophagitis in clinical practice. Clin J Gastroenterol, 2017. 10(2): p. 87-102, DOI: https://doi.org/10.1007/s12328-017-0725-4.

  5. Mari A, Tsoukali E, Yaccob A (2020) Eosinophilic esophagitis in adults: a concise overview of an evolving disease. Korean J Fam Med 41(2):75–83. https://doi.org/10.4082/kjfm.18.0162

    Article  PubMed  PubMed Central  Google Scholar 

  6. Lucendo AJ, Arias Á (2017) The role of endoscopy in eosinophilic esophagitis: from diagnosis to therapy. 11(12):1135–1149

  7. Gomez-Aldana A et al (2019) Eosinophilic esophagitis: current concepts in diagnosis and treatment. World J Gastroenterol 25(32):4598–4613. https://doi.org/10.3748/wjg.v25.i32.4598

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Gomez Torrijos E, Gonzalez-Mendiola R, Alvarado M, Avila R, Prieto-Garcia A, Valbuena T, Borja J, Infante S, Lopez MP, Marchan E, Prieto P, Moro M, Rosado A, Saiz V, Somoza ML, Uriel O, Vazquez A, Mur P, Poza-Guedes P, Bartra J (2018) Eosinophilic esophagitis: review and update. Front Med 5:247. https://doi.org/10.3389/fmed.2018.00247

    Article  Google Scholar 

  9. Miehlke S et al (2020) Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence. Ther Adv Gastroenterol 13:1756284820927282

    Article  CAS  Google Scholar 

  10. Wong S, Ruszkiewicz A, Holloway RH, Nguyen NQ (2018) Gastro-oesophageal reflux disease and eosinophilic oesophagitis: what is the relationship? World J Gastrointest Pathophysiol 9(3):63–72. https://doi.org/10.4291/wjgp.v9.i3.63

    Article  PubMed  PubMed Central  Google Scholar 

  11. Kellerman R, Kintanar T (2017) Gastroesophageal reflux disease. Prim Care 44(4):561–573. https://doi.org/10.1016/j.pop.2017.07.001

    Article  PubMed  Google Scholar 

  12. Hunter S, Helmy D, Zayed N, El-Tayeb T, El-Serafy M (2014) Eosinophilic esophagitis in Egyptian adult patients presenting with upper gastrointestinal symptoms. Open J Gastroenterol 4(02):88–95. https://doi.org/10.4236/ojgas.2014.42015

    Article  Google Scholar 

  13. Fouad M, Fouad YM, Mokareb HA, Mohamed EA, Abdel-Rehim DM (2018) Prevalence of eosinophilic esophagitis in adult patients with upper gastrointestinal symptoms in a locality in upper Egypt. Clin Endosc 51(4):357–361. https://doi.org/10.5946/ce.2017.166

    Article  PubMed  PubMed Central  Google Scholar 

  14. Hirano I (2011) Eosinophilic esophagitis and gastroesophageal reflux disease: there and back again. Clin Gastroenterol Hepatol 9(2):99–101. https://doi.org/10.1016/j.cgh.2010.11.001

    Article  PubMed  Google Scholar 

  15. Sawada A, Hashimoto A, Uemura R et al (2019) Association between endoscopic findings of eosinophilic esophagitis and responsiveness to proton pump inhibitors. Endoscopy Int Open 7(4):E433

    Article  Google Scholar 

  16. Ravi K, Talley NJ, Smyrk TC, Katzka DA, Kryzer L, Romero Y, Arora AS, Alexander JA (2011) Low grade esophageal eosinophilia in adults: an unrecognized part of the spectrum of eosinophilic esophagitis? Dig Dis Sci 56(7):1981–1986. https://doi.org/10.1007/s10620-011-1594-1

    Article  PubMed  Google Scholar 

  17. Braunberger, R., Hanson, J. and Gonzalez, R. (2021) Eosinophilic esophagitis. Esophagus. Pathology outlines.com.

  18. Eluri S, Dellon ES (2015) Proton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differences. Curr Opin Gastroenterol 31(4):309–315. https://doi.org/10.1097/MOG.0000000000000185

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Young A (2020) Real-world data show efficacy of PPIs in EoE. 21 July 2020. Healio news. Gastroenterology.

Download references

Acknowledgements

Thanks to every person who shared in this work.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Mansoura Specialized Medical Hospital, Internal Medicine Department, Hepatology & Gastroenterology Unit, Faculty of Medicine, Mansoura University, Mansoura City, Egypt

    Nancy Abdel Fattah Ahmed

  2. Specialized Medical Hospital, Internal Medicine Department, Hepatology & Gastroenterology Unit, Faculty of Medicine, Mansoura University, Mansoura City, Egypt

    Hebat-Allah Moheb Amer & Islam Abd El-Hamid El-Zayyadi

  3. Pathology Department, Faculty of Medicine, Mansoura University, Mansoura City, Egypt

    Dina Abdallah Ibrahim

Authors
  1. Nancy Abdel Fattah Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hebat-Allah Moheb Amer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dina Abdallah Ibrahim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Islam Abd El-Hamid El-Zayyadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

NAFA: manuscript review, editing, design, and publishing. HAMA: literature search, clinical follow-up, and statistics. DAAI: histopathological studies. IAEE: idea of the study and data collection. All authors have read and approved the manuscript.

Corresponding author

Correspondence to Nancy Abdel Fattah Ahmed.

Ethics declarations

Ethics approval and consent to participate

The study protocol was investigated and approved by the Medical Ethics Research Team, Faculty of Medicine, Mansoura University (code number: MS.18. 12.392). Every case, after guaranteeing privacy, has been given verbal consent as most of the patients cannot read or write.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahmed, N.A.F., Amer, HA.M., Ibrahim, D.A. et al. Prevalence of esophageal eosinophilia in patients referred for diagnostic upper gastrointestinal endoscopy. Egypt Liver Journal 11, 63 (2021). https://doi.org/10.1186/s43066-021-00126-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43066-021-00126-3

Keywords